Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

SRZN

Surrozen, Inc./DE

CIK 0001824893 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$23.50
↑ 0.62 (2.71%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals, Ownership; Excluded: Options (no data)

Key stats

Market Cap
$272.84M
P/E Ratio
-0.80
EPS
-32.37
Dividend Yield
Not covered
52W Position
57%
Beta
1.17

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
-0.98
P/S
36.41
EV/Revenue
22.14
ROE
123.2%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 57%
$8.20$35.00

Latest Financials

2025-12-31 FY
Revenue
$3.48M
Net Income
-$242.03M
Total Assets
$98.73M
Free Cash Flow
-$30.37M

Recent news